Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, December 5, 2011

Statins--Cardiovascular benefit vs diabetes risk

You'll want to question your doctor on this.
Listen to the video.
http://radio.theheart.org/bob-harrington-show/2011/10/31/42-statinscardiovascular-benefit-vs-diabetes-risk?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+radiotheheartorg+%28radio.theheart.org%29
Statins have become a cornerstone therapy in the prevention of cardiovascular disease by helping to modify the risk profile of millions of people. But what about a possible connection between statin use and diabetes? Lipidologist and preventive expert Dr Michael Cobble joins the show to relate his examination of the data and clinical experience and share his thoughts on the advantages of statin use relative to the risk of diabetes.
See:
Should you start a statin in a newly diagnosed diabetic?
Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomized statins trials. Lancet 2010; 375:735-742. Available here.
Preiss D, Seshasai SR, Welsh P, et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy. JAMA 2011; 305:2556-2564. Available here.
High-dose statin therapy increases the risk of diabetes: Meta-analysis
Dr Cobble has served as an advisor or consultant for Abbott, AstraZeneca, and Bristol Myers-Squibb. He has served as a speaker of member of a speaker's bureau for Abbott, AstraZeneca, Bristol Myers-Squibb, Eli Lilly, Boehringer Ingelheim, Novo, and Forest. Dr Cobble is employed by Atherotech Cardiometabolic Diagnostic Lab and runs a private practice, Canyons Medical Center.
For Dr Harrington's disclosures, click here.
Posted by at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)